COVID-19 vaccine effectiveness in patients with hematologic malignancy

Dimpy P. Shah; Pankil K. Shah; Michael A. Thompson

doi:10.1111/tid.13850

COVID-19 vaccine effectiveness in patients with hematologic malignancy

Dimpy P. Shah, Pankil K. Shah, Michael A. Thompson

Department of Urology

Producción científica: Editorial › revisión exhaustiva

1 Cita (Scopus)

Idioma original	English (US)
Número de artículo	e13850
Publicación	Transplant Infectious Disease
Volumen	24
N.º	6
DOI	https://doi.org/10.1111/tid.13850
Estado	Published - dic 2022

ASJC Scopus subject areas

Transplantation
Infectious Diseases

Acceder al documento

10.1111/tid.13850

Otros archivos y enlaces

Citar esto

@article{1b1884a1ca7c4649bebe256e0a3e5158,

title = "COVID-19 vaccine effectiveness in patients with hematologic malignancy",

keywords = "SARS-CoV-2, blood cancer, breakthrough infections, leukemia, lymphoma, vaccine effectiveness",

author = "Shah, {Dimpy P.} and Shah, {Pankil K.} and Thompson, {Michael A.}",

year = "2022",

month = dec,

doi = "10.1111/tid.13850",

language = "English (US)",

volume = "24",

journal = "Transplant Infectious Disease",

issn = "1398-2273",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - COVID-19 vaccine effectiveness in patients with hematologic malignancy

AU - Shah, Dimpy P.

AU - Shah, Pankil K.

AU - Thompson, Michael A.

PY - 2022/12

Y1 - 2022/12

KW - SARS-CoV-2

KW - blood cancer

KW - breakthrough infections

KW - leukemia

KW - lymphoma

KW - vaccine effectiveness

UR - http://www.scopus.com/inward/record.url?scp=85135944139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85135944139&partnerID=8YFLogxK

U2 - 10.1111/tid.13850

DO - 10.1111/tid.13850

M3 - Editorial

C2 - 35584967

AN - SCOPUS:85135944139

SN - 1398-2273

VL - 24

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

IS - 6

M1 - e13850

ER -